Menu Close
  • Clinical
    • In the Literature
    • Key Clinical Questions
    • Interpreting Diagnostic Tests
    • Coding Corner
    • Clinical
    • Clinical Guidelines
    • POCUS
    • Literature Lounge
    • History of HM
  • Practice Management
    • Quality
    • Public Policy
    • How We Did It
    • Key Operational Question
    • Technology
    • Practice Management
  • Diversity
  • Career
    • Leadership
    • Education
    • Career
  • Pediatrics
  • HM Voices
    • Commentary
    • In Your Eyes
    • In Your Words
    • The Flipside
  • SHM Resources
    • Society of Hospital Medicine
    • Journal of Hospital Medicine
    • SHM Career Center
    • SHM Learning
    • SHM Converge
    • Join SHM
    • Converge Coverage
    • SIG Spotlight
    • Chapter Spotlight
    • From JHM
  • Industry Content
    • Patient Monitoring with Tech
An Official Publication of
  • Clinical
    • In the Literature
    • Key Clinical Questions
    • Interpreting Diagnostic Tests
    • Coding Corner
    • Clinical
    • Clinical Guidelines
    • POCUS
    • Literature Lounge
    • History of HM
  • Practice Management
    • Quality
    • Public Policy
    • How We Did It
    • Key Operational Question
    • Technology
    • Practice Management
  • Diversity
  • Career
    • Leadership
    • Education
    • Career
  • Pediatrics
  • HM Voices
    • Commentary
    • In Your Eyes
    • In Your Words
    • The Flipside
  • SHM Resources
    • Society of Hospital Medicine
    • Journal of Hospital Medicine
    • SHM Career Center
    • SHM Learning
    • SHM Converge
    • Join SHM
    • Converge Coverage
    • SIG Spotlight
    • Chapter Spotlight
    • From JHM
  • Industry Content
    • Patient Monitoring with Tech

Literature Lounge

  • Article

    When Less Is More: Aspirin in Patients with Chronic Coronary Syndrome Receiving Oral Anticoagulation

    June 18, 2026

    Mount Sinai Med-Lit Review Clinical Question: In patients with chronic coronary syndrome and high atherothrombotic risk on long-term oral anticoagulation, does the addition of aspirin improve...

  • Article

    Evaluation of Optimal Duration of DAPT After PCI When Stratified by Bleeding Risk

    June 18, 2026

    Mount Sinai Med-Lit Review Clinical question: What is the optimal duration of dual antiplatelet therapy (DAPT) after percutaneous coronary intervention (PCI) with drug-eluting stent (DES) placement...

  • Article

    High-Normal Potassium Levels Reduce Ventricular Arrhythmias and Related Adverse Outcomes in High-Risk Patients with ICDs

    June 18, 2026

    Mount Sinai Med-Lit Review Clinical question: Does actively increasing serum potassium to the high-normal range (4.5 to 5.0 mmol/L) reduce malignant ventricular arrhythmias, arrhythmia-related...

  • Article

    Acetylcholinesterase Inhibitors for Delirium Prevention: A Systematic Review and Meta-Analysis

    June 18, 2026

    Mount Sinai Med-Lit Review Clinical question: Do acetylcholinesterase inhibitors help reduce the occurrence and severity of delirium in hospitalized patients? Background: Delirium is a frequent...

  • Article

    Beta-Blockers after Myocardial Infarction without Reduced Ejection Fraction

    June 18, 2026

    Mount Sinai Med-Lit Review Clinical question: Are beta-blockers beneficial in patients discharged after receiving invasive care for a myocardial infarction (MI) and with preserved left ventricular...

  • Article

    Sodium Bicarbonate for Severe Metabolic Acidemia and Acute Kidney Injury: BICARICU-2

    June 18, 2026

    Mount Sinai Med-Lit Review Clinical question: Does sodium bicarbonate infusion in patients with moderate to severe acute kidney injury and severe metabolic acidosis reduce 90-day all-cause...

  • Article

    Peripheral Vasopressors Safe in Early Sepsis Resuscitation

    June 18, 2026

    Mount Sinai Med-Lit Review Clinical question: Can vasopressors be safely administered through a peripheral line? Background: Traditionally, clinicians have administered vasopressors through central...

  • Article

    Extended Low-Dose Apixaban After Provoked VTE Reduces Recurrence in Selected Patients

    June 18, 2026

    Mount Sinai Med-Lit Review Clinical question: Among patients with provoked venous thromboembolism (VTE) and ongoing risk factors, does extending anticoagulation with low-dose apixaban reduce...

  • Article

    Aficamten Monotherapy is Superior to Metoprolol Monotherapy for Patients with Symptomatic Obstructive Hypertrophic Cardiomyopathy

    April 9, 2026

    NYU Langone Health Med-Lit Review Clinical Question: Is aficamten monotherapy superior to metoprolol monotherapy for patients with symptomatic obstructive hypertrophic cardiomyopathy? Background:...

  • Article

    Beta-Blockers After MI in Patients Without Heart Failure

    April 9, 2026

    NYU Langone Health Med-Lit Review Clinical Question: Does long-term beta-blocker therapy lower death or major adverse cardiovascular events in post-myocardial infarction (MI) patients with preserved...

1 2Next
  • About The Hospitalist
  • Contact Us
  • The Editors
  • Editorial Board
  • Authors
  • Publishing Opportunities
  • Subscribe
  • Advertise
  • Copyright © 2026 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies.
    ISSN 1553-085X
  • Privacy Policy
  • Terms and Conditions
  • Cookie Preferences